PMDA drug package insert
ヒアルロン酸Na点眼液0.1％「杏林」
PMDA Prescription drug · キョーリンリメディオ株式会社 · package insert Nov 13, 2024
Key facts
| Brand names | ヒアルロン酸Na点眼液0.1％「杏林」, ヒアルロン酸Na点眼液0.3％「杏林」 |
|---|---|
| Nonproprietary names | 精製ヒアルロン酸ナトリウム |
| Companies | 製造販売元／キョーリンリメディオ株式会社, 販売元／杏林製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 角結膜上皮障害治療用点眼剤 |
| Therapeutic category codes | 871319 |
| YJ codes | 1319720Q3191, 1319720Y2101 |
| Approval numbers | 22700AMX00118000, 22700AMX00722000 |
| Package insert edition | 第2版 |
| Package insert date | Nov 13, 2024 |
| PMDA document key | 480209_1319720Q3191_1 |
| PMDA company code | 480209 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: